Thomas F. Gajewski to Cost-Benefit Analysis
This is a "connection" page, showing publications Thomas F. Gajewski has written about Cost-Benefit Analysis.
Connection Strength
0.040
-
Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients. Ann Surg Oncol. 2021 Dec; 28(13):9039-9047.
Score: 0.040
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.